PF-06445974

Catalog No. :
ACAJZE227
CAS No. :
2055776-17-3
Molecular Formula :
C20H15FN4O
Molecular Weight :
346.36

IUPAC Name:4-(8-cyclopropyl-9-oxo-6,7,8,9-tetrahydropyrido[2',3':4,5]pyrrolo[1,2-a]pyrazin-10-yl)-2-fluorobenzonitrile

PF-06445974 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$171.00Login to see priceInquiryInquiry
5mg98%$375.00Login to see priceInquiryInquiry
10mg98%$600.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePF-06445974
IUPAC Name4-(8-cyclopropyl-9-oxo-6,7,8,9-tetrahydropyrido[2',3':4,5]pyrrolo[1,2-a]pyrazin-10-yl)-2-fluorobenzonitrile
Molecular FormulaC20H15FN4O
Molecular Weight346.36
SMILESN#CC1=CC=C(C(C2=NC=CC=C23)=C(N3CCN4C5CC5)C4=O)C=C1F
InChI KeyYWTCDMZVTLNYLN-UHFFFAOYSA-N
SynonymBenzonitrile, 4-(8-cyclopropyl-6,7,8,9-tetrahydro-9-oxopyrido[2',3':4,5]pyrrolo[1,2-a]pyrazin-10-yl)-2-fluoro-;PF-06445974;PF 6445974;PF6445974;PF-6445974
CAS No.2055776-17-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACAJZE227 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQAOK572 route compound structure diagram
    ACQAOK572843663-18-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAJZE227 route product structure diagram
    ACAJZE2272055776-17-3
Inquiry

2. ACAJZE227 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTQMY048 route compound structure diagram
    ACTQMY048870238-67-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAJZE227 route product structure diagram
    ACAJZE2272055776-17-3
Inquiry

Comments (0)